MedpageToday

184 articles in the TruthFoundry index. Each links out to the original.

• MedPage Today Shares Quotable Quotes from Medical Experts on Trials and Training · MedPage Today's weekly roundup features physician quotes on clinical trials, medical education, and research controversies.
• Study Finds Microplastics More Commonly in Lung Cancer Patients' Airways · Study of 100 bronchoscopy patients found microplastics in 66% of lung cancer patients vs 46% of controls.
• Long COVID Suffers from Disconnect Between Research and Diagnosis · Despite 17 million U.S. adults having long COVID, diagnosis rates remain low due to clinical challenges and policy shifts.
• TTHealthWatch Reviews Syncope Monitoring, PE Thrombolysis, Afib Ablation Studies · TTHealthWatch podcast covers NEJM syncope monitoring and PE thrombolysis trials, Lancet Afib ablation study, and cognitive health intervention.
• Doctors Must Challenge AI Recommendations, Essay Argues · A physician-writer argues doctors must challenge AI recommendations and keep human judgment, not machine authority, as final in medicine.
• MedPage Today Quiz Covers Vaccine Plea, Cancer Trust, and Statins · A medical news quiz covers an autism-vaccine researcher's guilty plea and other weekly topics.
• Mistrial Declared in Lindsay Clancy Murder Case After Failed Verdict · A judge declared a mistrial in the Lindsay Clancy case after jurors could not reach a unanimous verdict on her criminal responsibility.
• FDA Approves First New Blood Cancer Drug in 29 Years; AbbVie Announces Myeloma Win · FDA approves ropeginterferon alfa-2b for essential thrombocythemia; AbbVie reports positive phase III results for etentamig in multiple myeloma.
• Medical Researchers Alarmed by NIH Plan to Redirect Funds to Pentagon · Infectious disease specialists warn that a Trump administration plan to abolish an NIAID research unit may divert funds to defense spending.
• AI Tool Prof. Valmed Matches Physician Accuracy but Cuts Diagnosis Time in Trial · Prof. Valmed matched physician accuracy but cut diagnosis time from 206 to 94 seconds in a trial.
• FDA Approves Zilganersen as First Treatment for Alexander Disease · FDA approved zilganersen (Zanvastro), the first treatment for Alexander disease, targeting GFAP buildup in pediatric and adult patients.
• Alcohol-Attributable Cancer Deaths in US Doubled from 1990 to 2023, Study Finds · US alcohol-attributable cancer deaths doubled from 11,361 in 1990 to 23,126 in 2023, with the share of deaths linked to alcohol rising across most cancer types.
• UCSF Researcher Warns GLP-1 Drugs May Overlook Food Environment Driving Obesity · Laura Schmidt of UCSF argues in a MedPage Today interview that GLP-1 drugs alone won't solve obesity and that food environment policies are needed.
• NIH Deprioritizes Policy Research, Threatening Kidney Transplant System Improvements · NIH deprioritizes grants for policy research, jeopardizing evidence-based reforms for kidney transplant access.
• FENETRE Trial Shows Optometrists Can Safely Monitor Wet AMD, Ophthalmologists Urge Caution · FENETRE trial shows community optometrists monitor wet AMD as safely as hospitals, but ophthalmologists urge caution on expanding scope.
• Off-Label GLP-1 Prescriptions Surge 310-Fold in Young U.S. Kids · Off-label GLP-1 drug prescriptions for obese children aged 8-11 surged 310-fold since 2019 despite lacking FDA approval.
• Paxlovid No Better Than Placebo for Treating Long COVID Symptoms · A large NIH trial found nirmatrelvir-ritonavir offered no benefit over placebo for long COVID symptoms.
• Deadlocked Jury Sent Home in Lindsay Clancy Trial After Sixth Day · A deadlocked jury in the Lindsay Clancy trial was sent home without a verdict after deliberations stalled due to one juror's refusal to follow instructions.
• Unruptured Brain Aneurysms Found in 1 in 15 Healthy Adults · A systematic review shows unruptured brain aneurysm prevalence rose from 2.9% to 6.6% over two decades.
• GLP-1 Prescriptions Rise Sharper Among Adults With Serious Mental Illness · Analysis of U.S. insurance data shows GLP-1 drug prescriptions increased more rapidly for adults with serious mental illness than the general population between 2018 and 2024.
• Medical Professionals Share Insights on Trials, Safety, and Resilience · Healthcare workers discuss a new cardiology trial, sterile needle protocols, and personal medical experiences.
• FDA Expands Stelara Approval for Children; New IBD and Celiac Findings · FDA expanded Stelara approval for pediatric ulcerative colitis; new studies report on IBD risks and celiac treatments.
• Oral Brepocitinib Shows Rapid Skin Improvement in Dermatomyositis Trial · Oral brepocitinib significantly improved skin symptoms and quality of life in patients with dermatomyositis compared to placebo.
• Dolly Parton's Humility and Authenticity Offer Lessons for Physicians · The article argues Dolly Parton's qualities make her an excellent role model for doctors.
• Gloria Steinem Quotes on Feminism, Abortion, and Roe v. Wade · Feminist icon Gloria Steinem shares blunt quotes on reproductive rights and democracy before her death at 92.
• FDA-Approved Pancreatic Cancer Drug Shows Promise in Lung Cancer · Oral RAS inhibitor daraxonrasib shows high response rates in metastatic lung cancer trials.
• New Trials Show Mixed Results for Atrial Fibrillation Ablation Techniques · Recent sham-controlled trials indicate pulmonary vein isolation failed to improve quality of life but reduced recurrence, while low-voltage zone ablation showed promise.
• Healthcare Professionals Indicted, Settled, and Suspended in Legal Actions · Multiple healthcare providers face legal consequences ranging from indictments to multi-million dollar settlements.
• Health Digest: Clancy Trial, CDC Fatigue Data, Pesticide Study · MedPage Today's September 3, 2026 digest covers the Clancy trial, CDC fatigue data, and pesticide poisonings.
• UnitedHealthcare Removes 1,700 Prior Auth Codes Amid Mixed Expert Reactions · UnitedHealthcare eliminated 1,700 prior authorization codes, drawing cautious praise from experts who note the limited scope of the change.